China Pharma Holdings (CPHI) Change in Account Payables (2016 - 2025)
Historic Change in Account Payables for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $54437.0.
- China Pharma Holdings' Change in Account Payables fell 7766.63% to $54437.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $202297.0, marking a year-over-year increase of 14301.99%. This contributed to the annual value of -$733916.0 for FY2024, which is 33519.56% down from last year.
- Latest data reveals that China Pharma Holdings reported Change in Account Payables of $54437.0 as of Q3 2025, which was down 7766.63% from -$19322.0 recorded in Q2 2025.
- China Pharma Holdings' Change in Account Payables' 5-year high stood at $442807.0 during Q3 2023, with a 5-year trough of -$505339.0 in Q2 2024.
- Over the past 5 years, China Pharma Holdings' median Change in Account Payables value was -$3413.0 (recorded in 2022), while the average stood at -$30754.4.
- Per our database at Business Quant, China Pharma Holdings' Change in Account Payables surged by 304576.62% in 2023 and then crashed by 41487.08% in 2024.
- Quarter analysis of 5 years shows China Pharma Holdings' Change in Account Payables stood at $311018.0 in 2021, then fell by 23.32% to $238485.0 in 2022, then tumbled by 54.75% to $107922.0 in 2023, then plummeted by 244.32% to -$155753.0 in 2024, then surged by 134.95% to $54437.0 in 2025.
- Its last three reported values are $54437.0 in Q3 2025, -$19322.0 for Q2 2025, and $322935.0 during Q1 2025.